We obtained 78 human blood samples from areas in Haiti with high transmission of malaria and found no drug resistance-associated mutations in Plasmodium falciparum chloroquine resistance transporter and Kelch 13 genes. We recommend maintaining chloroquine as the first-line drug for malaria in Haiti. Artemisinin-based therapy can be used as alternative therapy.
CITATION STYLE
Vincent, J. P., Komaki-Yasuda, K., Existe, A. V., Boncy, J., & Kano, S. (2018, November 1). No plasmodium falciparum chloroquine resistance transporter and artemisinin resistance mutations, Haiti. Emerging Infectious Diseases. Centers for Disease Control and Prevention (CDC). https://doi.org/10.3201/eid2411.180738
Mendeley helps you to discover research relevant for your work.